000 | 01748 a2200505 4500 | ||
---|---|---|---|
005 | 20250513155748.0 | ||
264 | 0 | _c19990202 | |
008 | 199902s 0 0 eng d | ||
022 | _a0969-9961 | ||
024 | 7 |
_a10.1006/nbdi.1998.0197 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDeng, G | |
245 | 0 | 0 |
_aCloning and expression of a P2y purinoceptor from the adult bovine corpus callosum. _h[electronic resource] |
260 |
_bNeurobiology of disease _cOct 1998 |
||
300 |
_a259-70 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdenosine Triphosphate _xpharmacology |
650 | 0 | 4 | _aAmino Acid Sequence |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 | _aCattle |
650 | 0 | 4 | _aCloning, Molecular |
650 | 0 | 4 |
_aCorpus Callosum _xchemistry |
650 | 0 | 4 |
_aDNA, Complementary _xchemistry |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aElectrophysiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 |
_aOocytes _xdrug effects |
650 | 0 | 4 |
_aRNA _xadministration & dosage |
650 | 0 | 4 |
_aRNA Caps _xgenetics |
650 | 0 | 4 |
_aRNA, Messenger _xadministration & dosage |
650 | 0 | 4 |
_aReceptors, Purinergic P2 _xgenetics |
650 | 0 | 4 | _aSequence Analysis, DNA |
650 | 0 | 4 | _aXenopus |
700 | 1 | _aMatute, C | |
700 | 1 | _aKumar, C K | |
700 | 1 | _aFogarty, D J | |
700 | 1 | _aMiledi, R | |
773 | 0 |
_tNeurobiology of disease _gvol. 5 _gno. 4 _gp. 259-70 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1006/nbdi.1998.0197 _zAvailable from publisher's website |
999 |
_c9811205 _d9811205 |